These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 28064058)
1. Pectin-zinc-chitosan-polyethylene glycol colloidal nano-suspension as a food grade carrier for colon targeted delivery of resveratrol. Andishmand H; Tabibiazar M; Mohammadifar MA; Hamishehkar H Int J Biol Macromol; 2017 Apr; 97():16-22. PubMed ID: 28064058 [TBL] [Abstract][Full Text] [Related]
2. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction. Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release. Das S; Chaudhury A; Ng KY Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477 [TBL] [Abstract][Full Text] [Related]
4. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery. Amin MK; Boateng JS Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455 [No Abstract] [Full Text] [Related]
5. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Giovino C; Ayensu I; Tetteh J; Boateng JS Colloids Surf B Biointerfaces; 2013 Dec; 112():9-15. PubMed ID: 23928054 [TBL] [Abstract][Full Text] [Related]
6. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery. Pawar H; Douroumis D; Boateng JS Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474 [TBL] [Abstract][Full Text] [Related]
7. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of 5-fluorouracil and shikonin by blended and coated chitosan/pectin nanoparticles for treatment of colon cancer. Daneshmehr M; Pazhang M; Mollaei S; Ebadi M; Pazhang Y Int J Biol Macromol; 2024 Jun; 270(Pt 2):132413. PubMed ID: 38761911 [TBL] [Abstract][Full Text] [Related]
9. Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier. Das S; Ng KY Int J Pharm; 2010 Jan; 385(1-2):20-8. PubMed ID: 19833179 [TBL] [Abstract][Full Text] [Related]
10. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability. Hussain Z; Katas H; Yan SL; Jamaludin D Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178 [TBL] [Abstract][Full Text] [Related]
11. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats. Ahmed O; Abdel-Halim M; Farid A; Elamir A Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389 [TBL] [Abstract][Full Text] [Related]
13. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract. Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846 [TBL] [Abstract][Full Text] [Related]
14. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone. Gadalla HH; Soliman GM; Mohammed FA; El-Sayed AM Drug Deliv; 2016 Sep; 23(7):2541-2554. PubMed ID: 25853478 [TBL] [Abstract][Full Text] [Related]
15. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
16. Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation. Das S; Ng KY J Pharm Sci; 2010 Dec; 99(12):4903-16. PubMed ID: 20572052 [TBL] [Abstract][Full Text] [Related]
17. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. Das S; Ng KY; Ho PC J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen. Hassani Najafabadi A; Abdouss M; Faghihi S Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite. Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139 [TBL] [Abstract][Full Text] [Related]
20. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]